Park Ha Biological Technology Co Ltd (BYAH) Stock Analysis
Verdict: AVOID
Extreme valuation disconnect paired with a 99% price collapse suggests a broken IPO; cash runway is the only remaining asset.
Investment score: 8/100
Analysis as of
Is Park Ha Biological Technology Co Ltd stock worth reviewing? The TradeMates thesis
BYAH is a micro-cap disaster characterized by a 99.9% decline from its 52-week high and a total collapse in profitability. While it maintains a high gross margin, its operating expenses are nearly 10x its revenue. With a market cap of only $4.3M and a P/B over 21x, the TradeMates model sees no floor for this asset.
7-factor investment score
- Valuation: 5/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 2/100 (weight 15%)
- Earnings Quality: 5/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 0/100 (weight 10%)
- Risk-Adjusted Return: 5/100 (weight 15%)
Park Ha Biological Technology Co Ltd opportunities and risks
What speaks for BYAH
- Cash-to-Market Cap Ratio
What speaks against BYAH
- Imminent Liquidity Crisis / Dilution
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| BYAH | n/a | 0.2x | 0.1x | 91.2% | -840.7% | -26.1% |
| JWEL | n/a | 0.0x | n/a | 7.0% | -3.8% | -33.7% |
| Peer median | n/a | 0.0x | n/a | 7.0% | -3.8% | -33.7% |
Frequently asked questions about Park Ha Biological Technology Co Ltd (BYAH)
Is BYAH stock a good investment?
The TradeMates model rates Park Ha Biological Technology Co Ltd as AVOID with an investment score of 8/100. BYAH is a micro-cap disaster characterized by a 99.9% decline from its 52-week high and a total collapse in profitability. While it maintains a high gross margin, its operating expenses are nearly 10x its revenue. With a market cap of only $4.3M and a P/B over 21x, the TradeMates model sees no floor for this asset. This is algorithmic model output, not personal investment advice.
Is BYAH stock a buy?
The TradeMates model verdict for BYAH is AVOID with an investment score of 8/100. Treat this as a model signal to review, not a personal buy recommendation.